Efficacy and Safety Study of Ataciguat Versus Placebo in Patients With Neuropathic Pain

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

June 30, 2009

Study Completion Date

September 30, 2009

Conditions

Pain

Interventions

DRUG

ataciguat (HMR1766)

oral administration 200mg once daily for 28 days

DRUG

placebo

oral administration once daily for 28 days

Trial Locations (3)

Sanofi-Aventis Administrative Office, Vienna

Sanofi-Aventis Administrative Office, Prague

Sanofi-Aventis Administrative Office, Bucharest